Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prevalence of hearing loss in COVID-19 patients: a systematic review and meta-analysis

Prevalence of hearing loss in COVID-19 patients: a systematic review and meta-analysis Abstract Background and Objective ‘Hearing loss’ has been reported as a clinical atypical symptom in some COVID-19 patients. We searched and collated the existing literature for a systematic review and meta-analysis to assess the prevalence of hearing loss during the COVID-19 epidemic. Methods An exhaustive search of the PubMed, Embase, Web of Science, China National Knowledge Infrastructure and other sources from the inception of the database until 31st December 2022. The Search terms were set to: ‘COVID-19’, ‘SARS-CoV-2’, ‘2019-nCoV’, ‘hearing impairment’, ‘hearing loss’, ‘auditory dysfunction’. The literature data meeting the inclusion criteria were extracted and analyzed. Prevalence was pooled from individual studies using a randomized effects meta-analysis. Results A total of 22 studies were included in the final analysis, involving 14281 patients with COVID-19 infection, of which 482 patients had varying degrees of hearing loss. Our final meta-analysis demonstrated that the prevalence of hearing loss in COVID-19-positive patients was 8.2% (95%CI 5.0–12.1). Subgroup analysis of age showed that the prevalence of middle-aged and older patients aged 50-60 and over 60 years was 20.6% and 14.8%, respectively, which was significantly higher than that of patients aged 30–40 (4.9%) and 40–50 years (6.0%). Conclusion Hearing loss is one of the clinical symptoms of COVID-19 infection, compared with other diseases, it is less likely to attract the attention of clinical experts or researchers. Raising awareness of this disease can not only enable early diagnosis and treatment of hearing loss, and improve the quality of life of patients, but also enhance our vigilance against virus transmission, which has important clinical and practical significance. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Oto-Laryngologica Taylor & Francis

Prevalence of hearing loss in COVID-19 patients: a systematic review and meta-analysis

Acta Oto-Laryngologica , Volume 143 (5): 7 – May 2, 2023
7 pages

Loading next page...
 
/lp/taylor-francis/prevalence-of-hearing-loss-in-covid-19-patients-a-systematic-review-xvi9nbJ3nl

References (20)

Publisher
Taylor & Francis
Copyright
© 2023 Acta Oto-Laryngologica AB (Ltd)
ISSN
1651-2251
eISSN
0001-6489
DOI
10.1080/00016489.2023.2204909
Publisher site
See Article on Publisher Site

Abstract

Abstract Background and Objective ‘Hearing loss’ has been reported as a clinical atypical symptom in some COVID-19 patients. We searched and collated the existing literature for a systematic review and meta-analysis to assess the prevalence of hearing loss during the COVID-19 epidemic. Methods An exhaustive search of the PubMed, Embase, Web of Science, China National Knowledge Infrastructure and other sources from the inception of the database until 31st December 2022. The Search terms were set to: ‘COVID-19’, ‘SARS-CoV-2’, ‘2019-nCoV’, ‘hearing impairment’, ‘hearing loss’, ‘auditory dysfunction’. The literature data meeting the inclusion criteria were extracted and analyzed. Prevalence was pooled from individual studies using a randomized effects meta-analysis. Results A total of 22 studies were included in the final analysis, involving 14281 patients with COVID-19 infection, of which 482 patients had varying degrees of hearing loss. Our final meta-analysis demonstrated that the prevalence of hearing loss in COVID-19-positive patients was 8.2% (95%CI 5.0–12.1). Subgroup analysis of age showed that the prevalence of middle-aged and older patients aged 50-60 and over 60 years was 20.6% and 14.8%, respectively, which was significantly higher than that of patients aged 30–40 (4.9%) and 40–50 years (6.0%). Conclusion Hearing loss is one of the clinical symptoms of COVID-19 infection, compared with other diseases, it is less likely to attract the attention of clinical experts or researchers. Raising awareness of this disease can not only enable early diagnosis and treatment of hearing loss, and improve the quality of life of patients, but also enhance our vigilance against virus transmission, which has important clinical and practical significance.

Journal

Acta Oto-LaryngologicaTaylor & Francis

Published: May 2, 2023

Keywords: COVID-19; SARS-CoV-2; hearing loss; prevalence

There are no references for this article.